Pharmacists in Chatham, New Jersey


14 Pharmacists found in Chatham
male pharmacist

Mr. Alan Richard Brown, R. PH.


Pharmacist
195 Main St, Chatham, NJ 07928
973-635-6200     973-635-6208

male pharmacist

Dr. Benjamin Kyle Stevens, PHARMD


Pharmacist
195 Main St, Chatham, NJ 07928
973-635-6200    

female pharmacist

Bianca R Papay, RPH


Pharmacist
471 Main St, Chatham, NJ 07928
973-635-4636    



male pharmacist

Brian Knudsen


Pharmacist
471 Main St, Chatham, NJ 07928
732-406-3268    

male pharmacist

Mr. Dana Bruce Noblett, RPH


Pharmacist
195 Main St, Chatham, NJ 07928
973-635-6200     973-635-6208

female pharmacist

Mrs. Daniele Basralian


Pharmacist
471 Main St, Chatham, NJ 07928
973-635-4636    

female pharmacist

Dina Mohamed


Pharmacist
420 River Rd, Apt C5, Chatham, NJ 07928
901-338-5599    

female pharmacist

Jaclyn Christine Harabedian, PHARMD


Pharmacist
641 Shunpike Rd, Chatham, NJ 07928
973-301-3232    

male pharmacist

Joel Jarman


Pharmacist
195 Main St, Chatham, NJ 07928
973-635-6200     973-635-6208

female pharmacist

Leila S Kutuzova, RPH


Pharmacist
195 Main St, Chatham, NJ 07928
973-635-6200    

female pharmacist

Dr. Magne Elena Saba


Pharmacist
471 Main St, Chatham, NJ 07928
973-635-4636    

female pharmacist

Mrs. Michele Robyn Levine, R.PH.


Pharmacist - Nutrition Support
195 Main St, Chatham, NJ 07928
973-635-6200    

female pharmacist

Mrs. Renee Odonnell, RPH


Pharmacist
195 Main St, Chatham, NJ 07928
973-635-6207     973-635-6208

male pharmacist

William S Kubis, RPH.


Pharmacist
641 Shunpike Rd, Chatham, NJ 07928
973-301-3232    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.